News

16 September 2022

Medical devices: what are they, and how do we know that they’re safe?

In this instalment of In conversation with, we chat to Bryan Lister, our senior regulatory affairs consultant specialising in medical and IVD devices. We...

Read Insight
09 May 2022

Healthcare regulatory affairs agency appoints senior consultant to expand reach into medical devices market

Regulatory affairs consultancy Woodley BioReg has appointed Bryan Lister as senior regulatory affairs consultant, specialising in medical devices and human tissue. With over 30...

Read Insight
11 April 2022

Regulatory affairs consultancy expands into Europe with launch of Italian subsidiary and office

Forms Italian business entity Woodley BioReg Srl Opens office in Milan Aims to provide seamless experience to clients entering the EU market Drug and...

Read Insight
08 February 2022

Trio of key appointments for regulatory affairs consultancy

Regulatory affairs consultancy, Woodley BioReg, has made three new hires in line with its global expansion plans, including Neil Beaumont as business development manager,...

Read Insight
27 January 2022

Woodley BioReg attends Arab Health 2022

Our team of expert consultants were eager to get back out connecting with people in person in 2022, as the pandemic severely limited travel...

Read Insight
20 January 2022

Woodley BioReg sponsors Skelmanthorpe United JFC Girls Under 16’s

Huddersfield-based regulatory affairs consultancy Woodley BioReg has sponsored Skelmanthorpe United Junior Football Club Girls Under 16’s team — with funds going towards this year’s kit. WBR...

Read Insight
06 October 2021

We’ll be at CPhI Worldwide in Milan … see you there?

We’re delighted to announce we are heading to Italy next month for three days at CPhI Worldwide! Are you going too? Woodley BioReg is...

Read Insight
our expertise

We unlock
your potential

01

Pharmaceutical

From defining the Target Product Profile (TPP) through the preclinical / nonclinical stage, clinical development, right through to licence submission and maintenance, we can support you in developing effective regulatory and quality strategies to bring your product to market on time, and within budget.
02

Biopharmaceuticals

Our expert biopharmaceutical consultants specialise in the development and registration of complex biologics and biosimilars. With our finger on the pulse of this cutting-edge industry, we can help you navigate the complex landscape of regulatory approval for biopharmaceuticals.
03

Devices and Diagnostics

Woodley BioReg’s medical device and IVD specialists have been instrumental in the development of regulations, and can guide you through the changing legislative environment globally, as regulators look to keep up with the pace of innovation in this sector — enabling us to provide real value through strategy and delivery, for any type of product.